Tag Archives: VTGN

Top 10 Casino Stocks To Watch For 2019

Michael E. Lewitt

Back in April, I recommended Caesars Entertainment Corp. (Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature.

If you haven’t gotten in already, you’ll want to do it soon.

After months of bitter wrangling, the much-beleaguered Caesars has finally reached a $5 billion deal with the private-equity sponsors that looted the company, Apollo Global Management, LLC (NYSE: APO) and TPG Capital (formerly Texas Pacific Group). Pending approval by the U.S. Bankruptcy Court in Chicago, CZR is now set to leave bankruptcy, get rid of its debt, and get back on its feet.

Of course, this means very good news for stockholders (like you, I hope).

Here’s why you can expect to start seeing profits…

CZR’s Bonds Are Recovering – and Its Stock Will, Too

The sad chapter of Caesars Entertainment’s ownership by these two private-equity firms appears to be mercifully coming to an end. The firms agreed to increase their offer to repay the creditors some (but not all) of the billions of dollars they looted from the company in a desperate and disgusting effort to save their ill-fated investment in the casino giant. While they will retain an equity interest in the company, a majority of the stock will be held by the creditors who suffered at their hands.

Top 10 Casino Stocks To Watch For 2019: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Paul Ausick]

    Telefônica Brasil SA (NYSE: VIV) dropped about 2.3% Wednesday to set a new 52-week low of $9.72. Shares closed at $9.95 on Tuesday and the stock’s 52-week high is $17.33. Volume totaled around 1.4 million, about 25% below the daily average. The company had no specific news.

  • [By Ethan Ryder]

    Windstream (NASDAQ: WIN) and Telefonica Brasil (NYSE:VIV) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

  • [By Max Byerly]

    Vivendi (EPA:VIV) received a €23.50 ($27.33) price target from stock analysts at Barclays in a research note issued on Friday. The brokerage currently has a “neutral” rating on the stock.

  • [By Ethan Ryder]

    UBS Group set a €25.50 ($29.65) target price on Vivendi (EPA:VIV) in a research note issued to investors on Friday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

Top 10 Casino Stocks To Watch For 2019: Enduro Royalty Trust(NDRO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Top 10 Casino Stocks To Watch For 2019: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Vistagen Therapeutics alerts:

    Investor’s Alert (Earnings Per Share) – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday— VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

    Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

  • [By Ethan Ryder]

    Vistagen Therapeutics (NASDAQ:VTGN) was given a $6.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

Top 10 Casino Stocks To Watch For 2019: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cryptosolartech (CURRENCY:CST) traded up 4.2% against the dollar during the 1-day period ending at 20:00 PM ET on October 6th. One Cryptosolartech token can now be purchased for approximately $0.0203 or 0.00000309 BTC on exchanges. Cryptosolartech has a total market capitalization of $1.30 million and approximately $247,044.00 worth of Cryptosolartech was traded on exchanges in the last 24 hours. During the last seven days, Cryptosolartech has traded 4.1% lower against the dollar.

Top 10 Casino Stocks To Watch For 2019: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gold Standard Ventures Corp (NYSEAMERICAN:GSV) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 6,511,796 shares, a drop of 7.7% from the April 30th total of 7,056,069 shares. Based on an average daily volume of 268,131 shares, the short-interest ratio is currently 24.3 days. Approximately 5.9% of the company’s stock are sold short.

Top 10 Casino Stocks To Watch For 2019: Templeton Dragon Fund Inc.(TDF)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about Templeton Dragon Fund Inc common stock (NYSE:TDF) have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Templeton Dragon Fund Inc common stock earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the financial services provider an impact score of 45.9946586007156 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Templeton Dragon Fund Inc common stock (NYSE:TDF) major shareholder City Of London Investment Grou bought 8,155 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were purchased at an average price of $22.87 per share, with a total value of $186,504.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 10 Casino Stocks To Watch For 2019: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Applied Materials Inc. (NASDAQ: AMAT) dropped about 5.3% Thursday to set a new 52-week low of $40.25. Shares closed at $42.50 on Wednesday and the stock’s 52-week high is $62.40. Volume totaled around 19million, about 40% below the daily average. The semiconductor equipment maker is turning into an over-priced house in a declining neighborhood.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Applied Materials (AMAT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Short interest in Applied Materials Inc. (NASDAQ: AMAT) decreased to 13.87 million shares. The previous reading was 16.51 million. Shares were trading at $39.19, in a 52-week range of $28.79 to $62.40.

  • [By Nicholas Rossolillo]

    That could cause anxiety, but it also spells opportunity for investors looking for a deal. Even the high-flying tech sector sports some real bargains these days. Three worth your consideration are Applied Materials (NASDAQ:AMAT), Micron Technology (NASDAQ:MU), and Vodafone (NASDAQ:VOD).

  • [By Ashraf Eassa]

    Although TSMC is an obvious beneficiary from the production of the A12 chip, there’s another company that’s poised to profit handsomely as Apple and other companies start building chips using TSMC’s (as well as other companies’) 7nm technologies: Applied Materials (NASDAQ:AMAT).

  • [By Jon C. Ogg]

    Applied Materials Inc. (NASDAQ: AMAT) typically has beaten its earnings and sales expectations. Apparently, the top U.S. player for semiconductor capital equipment is finding out that 29% in quarterly revenue growth (to $4.57 billion) and a 54% jump in operating income (to $1.22 per share) from a year ago aren’t enough in the face of expectations ahead.

Top 10 Casino Stocks To Watch For 2019: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Xerium Technologies (NYSE:XRM) has trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Xerium Technologies earned a news impact score of 0.17 on Accern’s scale. Accern also assigned press coverage about the industrial products company an impact score of 47.7306467260184 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Casino Stocks To Watch For 2019: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GlaxoSmithKline plc (NYSE:GSK) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 8,497,397 shares, a drop of 27.2% from the May 15th total of 11,675,520 shares. Based on an average daily volume of 2,406,543 shares, the short-interest ratio is currently 3.5 days.

  • [By Shane Hupp]

    Dean Capital Investments Management LLC acquired a new stake in GlaxoSmithKline plc (NYSE:GSK) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 20,362 shares of the pharmaceutical company’s stock, valued at approximately $821,000. GlaxoSmithKline comprises about 0.5% of Dean Capital Investments Management LLC’s portfolio, making the stock its 15th largest position.

  • [By Todd Campbell]

    Following the sharp sell-off in Sangamo’s shares, Lanphier agreed to step down as Sangamo’s CEO in June 2016. In his place, Sangamo’s board of directors hired Sandy Macrae, a GlaxoSmithKline (NYSE:GSK) veteran who had most recently been the global medical officer for Takeda Pharmaceuticals.

  • [By Chris Lange]

    GlaxoSmithKline PLC (NYSE: GSK) has a meeting with the FDA’s Pulmonary-Allergy Drugs Advisory Committee scheduled for July 25. The meeting is in regards to the firm’s supplementary Biologics License Agreement (sBLA) for its chronic obstructive pulmonary disease (COPD) treatment, mepolizumab.

  • [By George Budwell]

    As the company didn’t release any major clinical or regulatory news last month, Agenus’ shares appear to have gotten a boost mainly from the stronger-than-expected launch of GlaxoSmithKline’s (NYSE:GSK) shingles vaccine Shingrix.

Top 10 Casino Stocks To Watch For 2019: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Logan Wallace]

    News stories about Lightinthebox (NYSE:LITB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Lightinthebox earned a daily sentiment score of 0.04 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 46.3507616645709 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Blue Chip Stocks To Watch Right Now

Dividend growth investing can be a great way to boost your passive income over time. To do it right, though, you have to find stocks that can both grow their dividends faster than inflation and have sustainable free cash flows for the long haul.

Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely for its prospects as a dividend growth stock. The reason? Gilead only started doling out a dividend approximately three years ago this month. As a result, the company has yet to shed its well-earned image as a top growth stock within the broader investing community. 

Image Source: Getty Images.

However, I think this underappreciated dividend growth play is worth adding to your portfolio right now. Here’s why.      

Gilead’s risks are overstated

There are two big knocks against Gilead as a dividend growth stock. First off, the company’s hepatitis C franchise has literally imploded since hitting a high watermark in late 2015. Gilead has thus had to rely on its core HIV franchise to pick up the slack, and that strategy has so far failed to keep the company’s top line moving in the right direction. Despite several new product launches in HIV, the biotech’s top line remains on track to drop by a disastrous 20.3% this year.

Top 10 Blue Chip Stocks To Watch Right Now: Summit Midstream Partners, LP(SMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the many companies working to solve the Permian’s pipeline problems is Summit Midstream Partners (NYSE:SMLP). The master limited partnership (MLP) is currently working on a long-haul pipeline that would transport natural gas from the northwest portion of the region to a major hub in Texas. The project would not only provide needle-moving growth for Summit — and help support its sky-high 14.5%-yielding distribution — but it could be a crucial supply link for the industry.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Summit Midstream Partners (SMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Three high-yield dividend stocks that seem to be in danger of a dividend reduction are Summit Midstream Partners (NYSE:SMLP), Enbridge Energy Partners (NYSE:EEP), and Sunoco LP (NYSE:SUN). Investors are better off steering clear of this trio and considering safer options instead.

  • [By Joseph Griffin]

    Summit Midstream Partners (NYSE:SMLP) insider Brad N. Graves sold 5,000 shares of the stock in a transaction dated Thursday, May 17th. The stock was sold at an average price of $15.53, for a total transaction of $77,650.00. Following the sale, the insider now owns 61,225 shares of the company’s stock, valued at approximately $950,824.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Max Byerly]

    Summit Midstream Partners (NYSE:SMLP) released its quarterly earnings data on Thursday. The pipeline company reported ($0.18) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.30), MarketWatch Earnings reports. Summit Midstream Partners had a return on equity of 12.62% and a net margin of 17.59%. The business had revenue of $117.32 million during the quarter, compared to the consensus estimate of $106.68 million.

Top 10 Blue Chip Stocks To Watch Right Now: EQT Corporation(EQT)

Advisors’ Opinion:

  • [By ]

    In addition, Elliott Management, which often pushes for M&A and other strategic transactions at targeted companies, made investments in EQT Corp. (EQT) , CommVault Systems Inc. (CVLT) , Sabre Corp. (SABR) , Teradyne Inc. (TER)  and Windstream Holdings Inc. (WIN)

  • [By Ethan Ryder]

    Mount Yale Investment Advisors LLC acquired a new stake in shares of EQT Co. (NYSE:EQT) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,022 shares of the oil and gas producer’s stock, valued at approximately $191,000.

  • [By Matthew DiLallo, Jason Hall, and Tyler Crowe]

    Tyler, Jason, and I (Matt here) were recently discussing why natural gas stocks have taken it on the chin over the past year. While some have been the victim of their own mistakes, shares of many of the country’s largest gas-focused producers have lost value even though oil prices have been on the upswing. For example, the country’s leading gas producer, EQT Corp. (NYSE:EQT), has seen its stock tumble more than 20%, while other large gas-focused companies such as Antero Resources (NYSE:AR), Cabot Oil & Gas (NYSE:COG), and Southwestern Energy have declined between 5% and 15% over the past 12 months. Those sell-offs caught our attention. Here’s what we think is weighing down gas stocks these days. 

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was EQT Corp. (NYSE: EQT) which rose about 10% to $53.35. The stock’s 52-week range is $43.70 to $67.84. Volume was nearly 11 million compared to the daily average volume of 3.6 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was EQT Corp. (NYSE: EQT) which traded down over 5% at $49.72. The stock’s 52-week range is $43.70 to $67.84. Volume was 7.6 million compared to the daily average volume of nearly 4 million.

Top 10 Blue Chip Stocks To Watch Right Now: Ultra Clean Holdings, Inc.(UCTT)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Ultra Clean Holdings Inc. (NASDAQ:UCTT) declined 19.2% in July, according to data from S&P Global Market Intelligence, after the semiconductor equipment specialist announced mixed second-quarter 2018 results and disappointing forward guidance.

  • [By Max Byerly]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Ultra Clean alerts:

    Comparing Rubicon Technology (RBCN) & Ultra Clean (UCTT) (americanbankingnews.com) Ultra Clean Holdings Inc (UCTT) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com) Spiffy Stocks: Daktronics, Inc. (NASDAQ:DAKT), Ultra Clean Holdings, Inc. (NASDAQ:UCTT), Galectin Therapeutics, Inc … (thestreetpoint.com) Ultra Clean Holdings, Inc. — Moody’s assigns B1 CFR to Ultra Clean Holdings; outlook stable (finance.yahoo.com)

    Several analysts recently weighed in on UCTT shares. Zacks Investment Research cut Ultra Clean from a “hold” rating to a “strong sell” rating in a report on Friday, August 3rd. BidaskClub raised Ultra Clean from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 30th. Stifel Nicolaus lifted their price target on Ultra Clean from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Monday, June 18th. Standpoint Research raised Ultra Clean from a “hold” rating to a “buy” rating in a report on Tuesday, August 28th. Finally, ValuEngine cut Ultra Clean from a “sell” rating to a “strong sell” rating in a report on Friday, May 18th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. Ultra Clean presently has a consensus rating of “Hold” and an average target price of $28.20.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Motley Fool Transcribing]

    Ultra Clean Holdings (NASDAQ:UCTT) Q4 2018 Earnings Conference CallFeb. 21, 2019 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Headlines about Ultra Clean (NASDAQ:UCTT) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Ultra Clean earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned media stories about the semiconductor company an impact score of 45.3293552269826 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Shane Hupp]

    Employees Retirement System of Texas reduced its stake in shares of Ultra Clean Holdings Inc (NASDAQ:UCTT) by 24.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,000 shares of the semiconductor company’s stock after selling 57,000 shares during the quarter. Employees Retirement System of Texas owned 0.46% of Ultra Clean worth $2,938,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Watch Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.19. Investors who bought at $2.55 are sitting on a 53.3% loss today (Feb. 20).

  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

Top 10 Blue Chip Stocks To Watch Right Now: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    1ST RES BK EXTO/SH (OTCMKTS:FRSB) and First of Long Island (NASDAQ:FLIC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

  • [By Logan Wallace]

    First of Long Island Corp (NASDAQ:FLIC) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.30 and last traded at $21.60, with a volume of 237 shares. The stock had previously closed at $21.50.

  • [By Stephan Byrd]

    First of Long Island (NASDAQ:FLIC) and 1ST RES BK EXTO/SH (OTCMKTS:FRSB) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “First of Long Island Corp (FLIC) Position Trimmed by ClariVest Asset Management LLC” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4167612/first-of-long-island-corp-flic-position-trimmed-by-clarivest-asset-management-llc.html.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Watch Right Now: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Lee Jackson]

    Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Maxx Chatsko]

    Shares of AxoGen (NASDAQ:AXGN) fell nearly 19% today after the company reported second-quarter 2018 earnings. The healthcare company, which develops and markets surgical solutions for peripheral nerves, actually reported a solid quarter of sales growth compared to the year-ago period. Revenue increased 36% compared to the second quarter of 2017.

  • [By Max Byerly]

    AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

Top 10 Blue Chip Stocks To Watch Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By ]

    On Tuesday, BP (BP) , Merck (MRK) , Under Armour (UAA) and Apple (AAPL) will be reporting. Cramer was bullish on all of them, except Apple, where he said this Action Alerts PLUS holding could report a less-than-optimal quarter.

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded up about 2.55% at $55.12. The stock’s 52-week range is $52.97 to $66.41. Volume was about 30% below the daily average of around 13 million. The company had no specific news.

  • [By Todd Campbell]

    Because statins are so widely used, they’re the most prescribed medicines in the world, and that’s been a bonanza for companies like Pfizer (NYSE:PFE), which developed top-selling cholesterol drug Lipitor, and Merck & Co. (NYSE:MRK), which created cholesterol-lowering add-on therapy Zetia.

  • [By Money Morning News Team]

    BioLine has developed key partnerships with major pharmaceutical companies, which helps bring its drugs to market faster once they have gained some clinical trial success. Two of its biggest partners are Merck & Co. Inc. (NYSE: MRK) and Novartis AG (NYSE: NVS).

  • [By ]

    While immunotherapy has definitely been a revolutionary advance in science and medicine, it has not been the panacea some had hoped for. For one, it’s not a cure. Further, this approach works better for some types of cancers than for others. Merck’s (NYSE: MRK) cancer treatment Keytruda, for instance, is FDA-approved for specific forms and stages of melanoma, lung cancer, neck cancer, classical Hodgkin Lymphoma and a few more — a lot, but still not a universal cure. Sales of Keytruda, however, exceeded $1 billion in the third quarter of 2017, which was reported Oct. 27. (Some missteps from Merck’s closest competitor, Bristol-Myers Squibb (NYSE: BMY), helped too.)

  • [By Chris Lange]

    The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 19.98 million from 20.40 million in the previous period. Its shares were trading at $59.40, in a 52-week range of $52.83 to $66.41.

Top 10 Blue Chip Stocks To Watch Right Now: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of Apogee Enterprises (NASDAQ:APOG) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, including gains of nearly 200 points for the Dow Jones Industrial Average and similarly positive moves for other major benchmarks. At first glance, decisions from the U.S. and China to impose new tariffs on each other might have seemed like bad news, but investors were pleased that the actual tariff rates on the goods covered by the measures were less severe than initially feared. Even with that as a positive backdrop, some companies weren’t able to avoid bad news that sent their shares lower. Tesla (NASDAQ:TSLA), Apogee Enterprises (NASDAQ:APOG), and General Mills (NYSE:GIS) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Stocks to Watch Today: V, MA, AAPL, GOOGL
    Visa Inc. (NYSE: V) and Mastercard Inc. (NYSE: MA) are under the microscope this morning. Both payment processing giants have signed a settlement agreement over a merchant lawsuit filed back in 2005, but originally settled in 2012 over merchant swiping fees. Visa will pay an additional $600 million to the original settlement. Mastercard will pay an additional $108 million. Although President Trump plans to hit China with new tariffs, at least one company won’t face the full cost: Apple Inc. (NASDAQ: AAPL). According to reports, the Apple Watch is among a list of consumer tech gadgets that will receive exemptions from the latest round of tariffs on imports. Alphabet Inc. (NASDAQ: GOOGL) announced it will install its Android operating system into automobiles manufactured by Nissan, Mitsubishi, and Renault. The operating system – set for distribution in 2021 – will include Google Maps, Google Assistant, and Google Play. The three manufacturers combined sold 10.6 million vehicles in 2017. Look for earnings reports from AutoZone Inc. (NYSE: AZO), General Mills Inc. (NYSE: GIS), Cracker Barrel Old Country Store Inc. (NASDAQ: CBRL), and Apogee Enterprises Inc. (Nasdaq: APOG).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By ]

    Engaged Capital’s Glenn Welling plans shortly to launch an activist campaign at Apogee Enterprises Inc. (APOG) , a maker of glass and non-residential construction products for skyscrapers, a person familiar with the situation told Orol.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Apogee Enterprises (APOG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

Top 10 Blue Chip Stocks To Watch Right Now: Bluerock Residential Growth REIT, Inc.(BRG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Bluerock Residential Growth REIT (NASDAQ:BRG) has trended somewhat positive on Sunday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bluerock Residential Growth REIT earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the company an impact score of 47.1792961215955 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Shane Hupp]

    A number of research analysts have commented on BRG shares. Zacks Investment Research raised shares of Bluerock Residential Growth REIT from a “hold” rating to a “buy” rating and set a $12.00 target price on the stock in a research report on Friday, February 15th. Boenning Scattergood reissued a “buy” rating and set a $11.00 target price on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. B. Riley reissued a “buy” rating on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. Finally, TheStreet raised shares of Bluerock Residential Growth REIT from a “d+” rating to a “c-” rating in a research report on Thursday, January 24th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $11.17.

    COPYRIGHT VIOLATION NOTICE: “Bluerock Residential Growth REIT Inc (BRG) Shares Sold by National Asset Management Inc.” was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4188619/bluerock-residential-growth-reit-inc-brg-shares-sold-by-national-asset-management-inc.html.

    About Bluerock Residential Growth REIT

  • [By Shane Hupp]

    Bluerock Residential Growth REIT Inc Class A (NYSEAMERICAN:BRG) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 1,697,945 shares, a decrease of 7.7% from the August 15th total of 1,840,022 shares. Approximately 7.2% of the shares of the company are short sold. Based on an average daily trading volume, of 110,334 shares, the days-to-cover ratio is presently 15.4 days.

Top 10 Blue Chip Stocks To Watch Right Now: Valmont Industries, Inc.(VMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Valmont Industries (VMI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Schroder Investment Management Group cut its stake in Valmont Industries (NYSE:VMI) by 1.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 689,795 shares of the industrial products company’s stock after selling 9,086 shares during the period. Schroder Investment Management Group owned approximately 3.06% of Valmont Industries worth $100,917,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Alps Advisors Inc. bought a new stake in Valmont Industries, Inc. (NYSE:VMI) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,686 shares of the industrial products company’s stock, valued at approximately $611,000.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Valmont Industries (VMI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Rhumbline Advisers reduced its stake in Valmont Industries, Inc. (NYSE:VMI) by 1.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,597 shares of the industrial products company’s stock after selling 598 shares during the period. Rhumbline Advisers owned 0.19% of Valmont Industries worth $6,271,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    A number of analysts have recently commented on VMI shares. Boenning Scattergood restated a “hold” rating on shares of Valmont Industries in a report on Wednesday, October 24th. ValuEngine upgraded Valmont Industries from a “sell” rating to a “hold” rating in a report on Thursday, November 1st. Finally, Zacks Investment Research downgraded Valmont Industries from a “hold” rating to a “sell” rating in a research report on Saturday, January 5th. Four equities research analysts have rated the stock with a hold rating, The company presently has an average rating of “Hold” and an average price target of $165.00.

    TRADEMARK VIOLATION NOTICE: “Valmont Industries (VMI) to Release Earnings on Wednesday” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at www.tickerreport.com/banking-finance/4147439/valmont-industries-vmi-to-release-earnings-on-wednesday.html.

    Valmont Industries Company Profile

Top 5 Low Price Stocks To Invest In Right Now

Analysis focus: RARE

Ultragenyx (NASDAQ:RARE), which we recommended as a buy in October 2017 when it was trading at 52-week lows, has been up 50% since our recommendation. We recommended it on the basis of an upcoming approval of its Sly syndrome treatment MEPSEVII in November – which happened; and another approval of borosumab (Crysvita) in April – which also happened. We also liked its cash position, both then and now, and its sale of a Rare Disease Priority Review voucher for $130mn. We didn’t like its two trial failures from before, and its overpaid purchase of another drug company – but those were already factored into the low price, and the new catalysts, we assumed, would take the stock higher. This too, happened.

The latest news for RARE Is that its Crysvita showed that it could beat conventional therapy in pediatric patients with X-linked hypophosphatemia (XLH), an inherited form of rickets (vitamin D deficiency). These conventional therapies for this rare disease, with about 12,000 patients in the US, are oral phosphate and active vitamin D, which have been used traditionally to improve pediatric rickets. Borosumab demonstrated superiority to these therapies, as we would expect since its approval. The molecule is a “fully human recombinant monoclonla IgG1 antibody that binds to (inhibits) the phosphaturic hormone fibroblast growth factor 23 (FGF23), a hormone that reduces blood levels of phosphorus and active vitamin D by regulating phosphate excretion and active vitamin D production by the kidney.”

Top 5 Low Price Stocks To Invest In Right Now: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Cory Renauer]

    The North American Marijuana Index, which tracks the leading cannabis stocks in the U.S. and Canada, is right about where it was to start the year despite surging over the past few months of 2017. The same could be said for one of Canada’s larger growers. Aphria (NASDAQOTH:APHQF) stock has risen in recent weeks, but it’s still a bit below a peak it achieved in January. 

  • [By Sean Williams]

    According to BNN Bloomberg, Ontario-based Aphria (NASDAQOTH:APHQF) was, at one time, the apple of Coke’s eye. A source familiar with the matter notes that Coca-Cola held talks with senior management at Aphria a few months ago, but that no agreement was reached. The thing is, Aphria has just as much of a pedigree as a partner as Aurora Cannabis does. 

  • [By Keith Speights]

    Since we’re already talking about Aurora and Canopy, it makes sense to jump to the Canadian market next. Both companies are poised to enjoy tremendous sales growth with the opening of the Canadian recreational market. However, I’d put Aphria (NASDAQOTH:APHQF), Cronos Group (NASDAQ:CRON), and Tilray (NASDAQ:TLRY) on the list for top stocks for the Canadian market as well. Each of these three companies could also be major players in Germany alongside Aurora and Canopy.

  • [By Sean Williams]

    Right now, Cronos Group commands a market cap that’s just north of $1 billion. By comparison, Aphria (NASDAQOTH:APHQF) has 230,000 kilograms of fully funded capacity under construction, and it’s only valued at $1.6 billion. Aphria One and Aphria Diamond (the company’s joint venture with Double Diamond Farms) both dwarf Peace Naturals with respective annual yields of 100,000 kilograms and 120,000 kilograms. This is noteworthy since the cannabis industry often benefits from economies of scale. In other words, an increase in production usually leads to a decrease in costs, at least on a per-gram basis. 

  • [By Keith Speights]

    If year-to-date performance were the deciding factor on which stock to buy, there would be no contest between Aphria (NASDAQOTH:APHQF) and MariMed (NASDAQOTH:MRMD). Aphria has lost nearly half of its market cap. MariMed ranked as the best-performing marijuana stock of the first half of 2018. Its share price is now up more than 260% so far this year.

Top 5 Low Price Stocks To Invest In Right Now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Janney Montgomery Scott LLC lifted its stake in Gaming and Leisure Properties Inc (NASDAQ:GLPI) by 13.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,286 shares of the real estate investment trust’s stock after acquiring an additional 2,564 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Gaming and Leisure Properties were worth $798,000 as of its most recent SEC filing.

  • [By Rich Duprey]

    Below is a mix of all of these types of companies. The stocks under my magnifying glass are Facebook (NASDAQ:FB), Macy’s (NYSE:M), and Gaming & Leisure Properties (NASDAQ:GLPI). Read on to see what’s wrong with two of these companies, and why the third one is a superior business.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Gaming and Leisure Properties (GLPI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Vistagen Therapeutics (NASDAQ:VTGN) was given a $6.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up 177%, from $0.92 to $2.55, on Dec. 6, when it announced it won a patent for its CNS treatment.

Top 5 Low Price Stocks To Invest In Right Now: Ctrip.com International, Ltd.(CTRP)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Ctrip.com International (NASDAQ:CTRP) Q1 2018 Earnings Conference CallMay. 22, 2018 8:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Traders purchased shares of Ctrip.Com International Ltd (NASDAQ:CTRP) on weakness during trading hours on Tuesday. $83.84 million flowed into the stock on the tick-up and $38.29 million flowed out of the stock on the tick-down, for a money net flow of $45.55 million into the stock. Of all companies tracked, Ctrip.Com International had the 28th highest net in-flow for the day. Ctrip.Com International traded down ($1.32) for the day and closed at $49.90

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Three Stocks to Watch Today: GE, AMZN, JD
    General Electric Co. (NYSE: GE) shares are under pressure after the stock received a downgrade from Swiss bank UBS Group AG (NYSE: UBS). The investment bank cut its price target for GE from $16 to $13. The bank cited ongoing struggles at GE’s power division as it continues to lose market share. Amazon.com Inc. (Nasdaq: AMZN) stock is on pace to overtake Apple Inc. (Nasdaq: AAPL) after it became the second company to achieve a $1 trillion market capitalization. The stock price has now doubled in a year thanks to its strong growth in retail sales and cloud computing. Apple needed 38 years to achieve the $1 trillion market cap while Amazon needed just 21 years. With that said, both AMZN and AAPL now comprise 8% of the entire S&P 500 market cap. Shares in JD.com Inc. (Nasdaq: JD) fell more than 5% in pre-market hours. Shares are on the decline after police said that its billionaire founder was arrested last week on charges of sexual assault. Look for additional earnings reports from Ctrip.com International Ltd. (Nasdaq: CTRP), Guidewire Software Inc. (Nasdaq: GWRE), Ollie’s Bargain Outlet Holdings Inc. (Nasdaq: OLLI), Vera Bradley Inc. (NYSE: VRA), and Verint Systems Inc. (Nasdaq: VRNT)

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ctrip.Com International (CTRP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Gramercy Property Trust (NYSE: GPT) rose 13.4 percent to $27.01 in pre-market trading after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    Warrior Met Coal, Inc. (NYSE: HCC) rose 9.1 percent to $30 in pre-market trading after climbing 5.61 percent on Friday.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 6.2 percent to $4.83 in pre-market trading after falling 48.35 percent on Friday.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 6 percent to $2.85 in pre-market trading after climbing 1.89 percent on Friday.
    Ctrip.com International, Ltd. (NASDAQ: CTRP) rose 4.8 percent to $43.15 in pre-market trading.
    G1 Therapeutics, Inc. (NASDAQ: GTHX) rose 3.2 percent to $44.00 in pre-market trading after climbing 6.92 percent on Friday.
    Synchrony Financial (NYSE: SYF) rose 3.2 percent to $33.68 in pre-market trading after gaining 2.03 percent on Friday.
    Starbucks Corporation (NASDAQ: SBUX) rose 3.1 percent to $59.45 in pre-market trading. Nestle announced plans to acquire rights to market, sell and distribute Starbucks Brands.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 5 Low Price Stocks To Invest In Right Now: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Mediwound (NASDAQ:MDWD) has been trending somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mediwound earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 47.1925876006011 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    Mediwound (NASDAQ: MDWD) and True Drinks (OTCMKTS:TRUU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Mediwound (MDWD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Invest In 2019

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1036378723&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1036378723/960×0.jpg?fit=scale&q; data-height=&q;622&q; data-width=&q;960&q;&g; Shutterstock

After a prolonged correction, Bitcoin is back big time. The &a;ldquo;people&a;rsquo;s currency&a;rdquo; gained close to 7% this week, stabilizing around the $11,000 mark.

Is this comeback for real?

Hard to say, as there are hardly any &a;ldquo;fundamentals&a;rdquo; to judge whether Bitcoin is undervalued or overvalued at these levels. Still, there are a couple of bullish signs for the digital currency worth noticing.

One of them is that Bitcoin is beginning to behave like the &a;lsquo;new gold,&a;rsquo; shining in times of extreme uncertainty that take over Wall Street.

There was a time when gold would shine as Wall Street faltered. That was long time ago, when it was the hedge against uncertainty. It was the asset where investors could park their cash in times of political and economic turmoil.

Top 10 Undervalued Stocks To Invest In 2019: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a generally favorable day for the stock market, with modest gains for most major benchmarks even as the Russell 2000 once again hit intraday record highs. Most investors’ attention was focused on the retail sector, where an especially strong performance from department store giant Macy’s suggested that the long period of difficult conditions for brick-and-mortar retailers might finally have come to an end. Ongoing concerns about other factors — including the move in the 10-year Treasury yield above the 3% mark and the outcome of a possible summit between U.S. and North Korean leaders — helped keep the gains somewhat in check. But some companies had good news that sent their shares sharply higher. Under Armour (NYSE:UA) (NYSE:UAA), Boot Barn Holdings (NYSE:BOOT), and Abaxis (NASDAQ:ABAX) were among the best performers on the day. Here’s why they did so well.

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $83.08. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $82.95. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

Top 10 Undervalued Stocks To Invest In 2019: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Cinemark (CNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Accelerate Your Gains: Stocks will make you money, but trading can set you up for life. With the secrets in this video series, you could potentially start collecting anywhere from $1,190, $1,313, and even $2,830 in consistent income – each and every week. See for yourself…

    Three Stocks to Watch Today: AAPL, DBX, STMP
    Shares of Dropbox Inc. (NYSE: DBX) plunged more than 10% after the company’s forward guidance fell well short of Wall Street expectations Thursday. Even though the firm topped quarterly earnings and revenue expectations, the cloud storage giant announced it would take a large write down on the value of its recent HelloSign acquisition. That will impact company margins in the year ahead, in addition to the firm’s plans to relocate offices to San Francisco, where rents are much higher. Apple Inc. (NASDAQ: AAPL) continues to remain in the headlines. The firm’s iPhone sales had been declining before the company decided to stop reporting unit sales beginning this year. But as Money Morning Chief Investment Strategist Keith Fitz-Gerald told readers in October 2017, Apple is no longer a device company. In fact, it hasn’t been a device company for years. Its shift into services has helped boost investor confidence, and it just made a major announcement that will target firms like Netflix Inc. (NASDAQ: NFLX) and Hulu. Apple is one of our top five stocks to buy right now. For the full list, go here now. Shares of Stamps.com Inc. (NASDAQ: STMP) plunged more than 50% in pre-market hours after the shipping products company announced it was ending its exclusive partnership with the USPS. The company also said it expected a massive downturn in profitability. The firm’s full-year guidance was set between $5.15 and $6.15. That is well below the $10.79 figure anticipated by analysts. During its earnings call last night, the firm’s CEO said that USPS would not accept the terms of its partnership proposal. On Friday, look for earnings reports from Aut

  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    Cinemark (NYSE:CNK) last released its quarterly earnings results on Wednesday, August 8th. The company reported $0.70 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.05). The business had revenue of $889.05 million during the quarter, compared to analyst estimates of $897.68 million. Cinemark had a net margin of 8.86% and a return on equity of 19.49%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.44 earnings per share. sell-side analysts anticipate that Cinemark Holdings, Inc. will post 1.99 earnings per share for the current year.

  • [By Rich Duprey]

    Movie theater chains are testing their own services, too. AMC Entertainment (NYSE:AMC) has launched Stubs A-List, offering three movies per week for $19.95 per month. Cinemark’s (NYSE:CNK) Movie Club offers one ticket per month for $8.99, but throws in 20% discounts on concessions (additional tickets can be purchased for $8.99 as well).

  • [By Shane Hupp]

    Blair William & Co. IL raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 6.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,906 shares of the company’s stock after purchasing an additional 1,929 shares during the period. Blair William & Co. IL’s holdings in Cinemark were worth $1,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Undervalued Stocks To Invest In 2019: Eagle Bancorp, Inc.(EGBN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Russell Investments Group Ltd. cut its holdings in shares of Eagle Bancorp, Inc. (NASDAQ:EGBN) by 14.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,011 shares of the financial services provider’s stock after selling 8,399 shares during the period. Russell Investments Group Ltd. owned 0.14% of Eagle Bancorp worth $3,004,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Eagle Bancorp (EGBN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    WARNING: “Eagle Bancorp, Inc. (EGBN) Holdings Trimmed by TIAA CREF Investment Management LLC” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at www.tickerreport.com/banking-finance/3353520/eagle-bancorp-inc-egbn-holdings-trimmed-by-tiaa-cref-investment-management-llc.html.

  • [By Logan Wallace]

    SG Americas Securities LLC purchased a new position in Eagle Bancorp, Inc. (NASDAQ:EGBN) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 2,686 shares of the financial services provider’s stock, valued at approximately $161,000.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Eagle Bancorp (EGBN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Eagle Bancorp, Inc. (NASDAQ:EGBN) has been assigned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $69.00.

Top 10 Undervalued Stocks To Invest In 2019: Costamare Inc.(CMRE)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of three big oceangoing container-shipping companies — Triton International (NYSE:TRTN), Seaspan (NYSE:SSW), and Costamare (NYSE:CMRE) — suffered huge losses in early trading Friday after Wells Fargo announced it was downgrading “the entire container complex,” as StreetInsider.com put it.

  • [By Logan Wallace]

    COSTAMARE Inc/SH (NYSE:CMRE) has received an average recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $7.75.

  • [By Logan Wallace]

    COSTAMARE Inc/SH (NYSE:CMRE) shares hit a new 52-week high during trading on Tuesday following a dividend announcement from the company. The stock traded as high as $8.15 and last traded at $8.10, with a volume of 15988 shares trading hands. The stock had previously closed at $7.98.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on COSTAMARE Inc/SH (CMRE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Invest In 2019: Laredo Petroleum, Inc.(LPI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Laredo Petroleum alerts:

    Q2 2018 EPS Estimates for Laredo Petroleum Inc (LPI) Reduced by Analyst (americanbankingnews.com) Laredo Working to Restart Permian Production Shuttered Following Tank Fire (naturalgasintel.com) OPEC Losing Control After Libya Outages (finance.yahoo.com) Laredo Petroleum reaffirms FY 2018 production view after storage tank fire (seekingalpha.com) Laredo Petroleum (LPI) Provides Update on Fire Reported at Tank Battery in Glasscock County, Texas (streetinsider.com)

    LPI stock traded down $0.15 during trading on Thursday, reaching $9.37. 204,560 shares of the stock were exchanged, compared to its average volume of 4,884,005. Laredo Petroleum has a twelve month low of $7.41 and a twelve month high of $13.46. The company has a market cap of $2.24 billion, a PE ratio of 15.62, a price-to-earnings-growth ratio of 1.79 and a beta of 1.16. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.90.

  • [By Joseph Griffin]

    Laredo Petroleum Inc (NYSE:LPI) – Piper Jaffray Companies decreased their Q4 2019 earnings per share estimates for Laredo Petroleum in a report released on Wednesday, February 13th. Piper Jaffray Companies analyst K. Harrison now forecasts that the oil and gas producer will post earnings per share of $0.11 for the quarter, down from their previous estimate of $0.12. Piper Jaffray Companies has a “Neutral” rating on the stock. Piper Jaffray Companies also issued estimates for Laredo Petroleum’s Q3 2020 earnings at $0.03 EPS.

  • [By Max Byerly]

    Laredo Petroleum Inc (NYSE:LPI) dropped 5.9% on Monday . The stock traded as low as $7.95 and last traded at $7.96. Approximately 3,201,738 shares were traded during trading, a decline of 16% from the average daily volume of 3,808,352 shares. The stock had previously closed at $8.46.

  • [By Shane Hupp]

    Laredo Petroleum Inc (NYSE:LPI) shares dropped 7.9% during mid-day trading on Friday . The stock traded as low as $8.41 and last traded at $8.61. Approximately 5,931,000 shares were traded during mid-day trading, an increase of 68% from the average daily volume of 3,529,008 shares. The stock had previously closed at $9.35.

  • [By Dan Caplinger]

    Wednesday was a relatively quiet day on Wall Street, with major market benchmarks closing the day mixed, but nearly flat. Market participants were briefly enthusiastic about the potential to set new record highs following reports that the U.S. and China were mulling further trade negotiations, but the positive impact of that announcement largely waned as the day progressed. Nevertheless, investors focusing on company-specific news found some reasons to celebrate. Altria Group (NYSE:MO), Galapagos (NASDAQ:GLPG), and Laredo Petroleum (NYSE:LPI) were among the best performers on the day. Below, we’ll look more closely at these businesses to tell you why their stocks did so well.

  • [By Matthew DiLallo]

    Shares of oil producers Laredo Petroleum (NYSE:LPI) and SM Energy (NYSE:SM), as well as units of Golar LNG Partners LP (NASDAQ:GMLP), an MLP that owns liquified natural gas carriers and floating storage and regasification units, all declined by double digits by Friday afternoon. Lower oil prices weighed on the first two, while an analyst downgrade was the culprit in the latter.

Top 10 Undervalued Stocks To Invest In 2019: Square, Inc.(SQ)

Advisors’ Opinion:

  • [By Brian Stoffel]

    For the purposes of this article, it has nothing to do with share price appreciation, and everything to do with the performance of the underlying companies. And when it comes to companies that are winning over customers in droves, few are doing a better job than e-commerce platform Shopify (NYSE:SHOP), digital payment specialist Square (NYSE:SQ), or food delivery guru GrubHub (NYSE:GRUB). 

  • [By Matthew Frankel, CFP]

    Person-to-person (P2P) payments have surged in popularity in recent years, and three leaders have emerged: PayPal’s (NASDAQ:PYPL) Venmo, Zelle, and Square’s (NYSE:SQ) cash app. In this episode of Industry Focus: Financials, host Shannon Jones and Fool.com contributor Matt Frankel discuss the three industry leaders and how their surge in popularity could translate into big profits in the future.

  • [By Travis Hoium]

    Shares of mobile payment company Square Inc (NYSE:SQ) have jumped 86.5% so far in 2018, according to data provided by S&P Global Market Intelligence, as operating conditions continue to improve. If the company’s growth keeps up, the sky is the limit for the stock. 

  • [By Jeremy Bowman, Leo Sun, and Steve Symington]

    Leo Sun (PayPal): PayPal, which was spun off of eBay (NASDAQ:EBAY) in 2015, popularized digital payments long before bitcoin became relevant. Unlike its industry peer Square (NYSE:SQ), PayPal refuses to add bitcoin transactions to its platform, saying that volatile prices make bitcoin unsuitable for payments.

Top 10 Undervalued Stocks To Invest In 2019: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.07. Investors who bought at $2.55 are sitting on a 58% loss today (Jan. 8).

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

Top 10 Undervalued Stocks To Invest In 2019: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By Rich Smith]

    Britain’s BAE Systems (NASDAQOTH:BAESF) (NASDAQOTH:BAESY) is a behemoth, doing more than $24 billion in annual business and valued in excess of $26 billion — yet it’s largely unknown to U.S. investors, a consequence of its stock being traded over the counter and not on major U.S. stock exchanges like the NYSE or Nasdaq. That could change, however, with BAE winning a big endorsement from investment megabank Morgan Stanley this morning.

  • [By Lou Whiteman]

    The Marine Corps has selected BAE Systems (NASDAQOTH:BAESY) to manufacture its next-generation amphibious combat vehicle, dealing a major setback to the diversification plans of Science Applications International (NYSE:SAIC).

  • [By Logan Wallace]

    BEACH ENERGY Lt/ADR (OTCMKTS:BCHEY) and BAE SYS PLC/S (OTCMKTS:BAESY) are both oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

  • [By Jason Hall, Rich Smith, and Travis Hoium]

    But that doesn’t mean investors looking to add defense stocks to their portfolio should avoid the entire sector; there are opportunities to be had. These Motley Fool contributors have identified two companies with substantial military and commercial opportunities in AeroVironment, Inc. (NASDAQ:AVAV) and Boeing Co. (NYSE:BA), as well as undervalued British defense giant BAE Systems PLC (ADR) (NASDAQOTH:BAESY) as defense stocks worth watching closely this month. 

Top 10 Undervalued Stocks To Invest In 2019: Advantage Lithium Corp. (AVLIF)

Advisors’ Opinion:

  • [By ]

    Advantage Lithium (OTCQX:AVLIF) is a strategic advanced junior lithium exploration company that operates between Lithium Americas and Orocobre in the Cauchari-Olaroz basin. Orocobre is the largest shareholder in the company with a 30% equity stake, coupled with a 25% interest in the project. Over the past few months, the company has been moving towards completing the second stage of its drilling campaign, which will be completed in May 2018 and will then be followed on with an updated Natural Resource Estimate Study. This will allow the company to move into phase three of its drilling efforts, which will utilize larger drills to further define the resource, with a Feasibility Study expected to be completed in the first part of 2019.

  • [By ]

    The following 6 companies are on the bench for the index:

    Advantage Lithium (OTCQX:AVLIF) Argosy Minerals (OTCPK:ARYMF) Bacanora Minerals (OTC:BCRMF) Critical Elements (OTCQX:CRECF) NEO Lithium (OTCQX:NTTHF) Wealth Minerals (OTCQX:WMLLF)

    “Bench” is a sports analogy meaning that one or more of them could be added in the future if one of the above companies becomes a producer, is acquired, or the market capitalization (“cap”) of one or more of the index holdings falls significantly below that of one or more companies on the bench.

  • [By ]

    Other juniors include: Advantage Lithium (OTCQB:AVLIF) [TSXV:AAL], AIS Resources [TSXV:AIS] (OTCQB:AISSF), American Lithium Corp. [TSX-V: LI] (OTCQB:LIACF), Argentina Lithium and Energy Corp. [TSXV:LIT] (OTCQB:PNXLF), Argosy Minerals [ASX:AGY] (OTC:ARYMF), AVZ Minerals [ASX:AVZ] (OTC:AZZVF), Bacanora Minerals [TSXV:BCN] [AIM:BCN] [GR:1BQ] (OTC:BCRMF), Birimian Ltd [ASX:BGS] (OTC:EEYMF), Critical Elements [TSXV:CRE] [GR:F12] (OTCQX:CRECF), Dajin Resources [TSXV:DJI] (OTCPK:DJIFF), Enigri (private), Eramet (EN Paris:ERA) (OTCPK:ERMAY), European Metals Holdings [ASX:EMH] [AIM:EMH] [GR:E861] (OTC:ERPNF), Far Resources [CSE:FAT] (OTCPK:FRRSF), Force Commodities [ASX:4CE], Kidman Resources [ASX:KDR] [GR:6KR], Latin Resources Ltd [ASX: LRS] (OTC:LAXXF), Lithium Australia [ASX:LIT] (OTC:LMMFF), Lithium Power International [ASX:LPI] (OTC:LTHHF), LSC Lithium [TSXV:LSC] (OTC:LSSCF), MetalsTech [ASX:MTC], MGX Minerals [CSE:XMG] (OTC:MGXMF), Millennial Lithium Corp. [TSXV:ML] (OTCQB:MLNLF), Neo Lithium [TSXV:NLC] (OTC:NTTHF), NRG Metals Inc. [TSXV:NGZ] (OTCQB:NRGMF), Nemaska Lithium [TSX:NMX] [GR:NOT] (OTCQX:NMKEF), North American Lithium (private), Piedmont Lithium [ASX:PLL] (OTC:PLLLY), Prospect Resources [ASX:PSC], Sayona Mining [ASX:SYA] (OTCPK:DMNXF), Savannah Resources [LSE:SAV], Standard Lithium [TSXV:SLL] (OTC:STLHF), and Wealth Minerals [TSXV:WML] (OTCQB:WMLLF).

Top 10 Undervalued Stocks To Invest In 2019: UMH Properties Inc.(UMH)

Advisors’ Opinion:

  • [By Shane Hupp]

    TRADEMARK VIOLATION NOTICE: “Loeb Partners Corp Has $1.44 Million Holdings in UMH PROPERTIES/SH SH (UMH)” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at www.tickerreport.com/banking-finance/4159809/loeb-partners-corp-has-1-44-million-holdings-in-umh-properties-sh-sh-umh.html.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on UMH PROPERTIES/SH SH (UMH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on UMH PROPERTIES/SH SH (UMH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on UMH PROPERTIES/SH SH (UMH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

Top Performing Stocks For 2019

May 24, 2017: Markets opened higher again Wednesday and while equities have stayed in the green all day, they have not strayed for from the break-even line. The energy and telecom sectors traded in the red while materials and real estate were the best performing sector. WTI crude oil for July delivery settled at $51.36 a barrel, down 0.2%. June gold also dipped 0.2% for the day to settle at $1,253.10. Equities were headed for a modestly higher close shortly before the bell as the DJIA traded up 0.39% for the day, the S&P 500 traded up 0.28%, and the Nasdaq Composite traded up 0.43%.

The DJIA stock posting the largest daily percentage gain ahead of the close Wednesday was E.I. du Pont de Nemours Inc. (NYSE: DD) which traded up 1.27% at $78.32. The stock’s 52-week range is $61.12 to $82.37. Volume was about 30% below the daily average of around 2.9 million shares. Activist investor Daniel Loeb of Third Point LLC said he sees another $20 billion in value by breaking up the merged Dow Chemical-DuPont company after the merger is completed.

Top Performing Stocks For 2019: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

  • [By Money Morning News Team]

    Consider one of the top penny stocks from December, VistaGen Therapeutics Inc. (Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up 177%, from $0.92 to $2.55, on Dec. 6, when it announced it won a patent for its CNS treatment.

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

Top Performing Stocks For 2019: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Max Byerly]

    KAMES CAPITAL plc decreased its holdings in shares of NetEase (NASDAQ:NTES) by 68.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,800 shares of the technology company’s stock after selling 39,277 shares during the period. KAMES CAPITAL plc’s holdings in NetEase were worth $4,991,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    These are some of the news headlines that may have effected Accern’s rankings:

    Get NetEase alerts:

    Study Stock Price Behavior with Financial Report for NetEase, Inc. (NTES) (finherald.com) Analysis of Analyst Stock Recommendation: NetEase, Inc. (NTES) (nasdaqplace.com) Notable Moving Tech Stock: NetEase, Inc. (NTES) (nasdaqplace.com) Investors must not feel shy to buy these Stocks: NetEase, Inc. (NASDAQ:NTES), YUM! Brands, Inc. (NYSE:YUM), Erie … (journalfinance.net) Destiny maker Bungie raises $100M from China’s NetEase to build new games (geekwire.com)

    NetEase traded up $3.95, hitting $243.58, during midday trading on Friday, MarketBeat.com reports. The stock had a trading volume of 1,182,914 shares, compared to its average volume of 1,423,698. The firm has a market cap of $31.99 billion, a price-to-earnings ratio of 19.63, a PEG ratio of 1.83 and a beta of 0.82. NetEase has a 1-year low of $222.32 and a 1-year high of $377.64.

  • [By Rick Munarriz]

    Many Chinese growth stocks have started bouncing back, but the same can’t be said about NetEase (NASDAQ:NTES). The Chinese online gaming pioneer hit another 52-week low earlier this month, and it’s trading nearly 30% below the all-time highs it hit late last year. 

  • [By Harsh Chauhan]

    NetEase (NASDAQ:NTES) has lost its wheels in recent quarters. Massive growth of the low-margin e-commerce business, as well as a slowdown in the video gaming business, has eroded the Chinese internet giant’s earnings power, and the situation was no different last quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Top Performing Stocks For 2019: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Daktronics Inc (NASDAQ:DAKT)Q1 2019 Earnings Conference CallAug. 21, 2018, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin]

    Shares of Daktronics, Inc. (NASDAQ: DAKT) were down 19 percent to $8.17 after reporting weaker-than-expected quarterly results.

    Michael Kors Holdings Limited (NYSE: KORS) was down, falling around 12 percent to $59.86. Michael Kors reported better-than-expected earnings for its fiscal fourth quarter and issued strong first-quarter guidance. However, the company issued cautious profit guidance for the full year.

  • [By Stephan Byrd]

    Shares of Daktronics, Inc. (NASDAQ:DAKT) have earned a consensus rating of “Hold” from the six analysts that are covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $10.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dick's Sporting Goods, Inc. (NYSE: DKS) is projected to report its quarterly earnings at $0.45 per share on revenue of $1.89 billion.
    Columbus McKinnon Corporation (NASDAQ: CMCO) is estimated to report its quarterly earnings at $0.5 per share on revenue of $209.35 million.
    Analog Devices, Inc. (NASDAQ: ADI) is expected to report its quarterly earnings at $1.38 per share on revenue of $1.47 billion.
    Michael Kors Holdings Limited (NYSE: KORS) is projected to report its quarterly earnings at $0.59 per share on revenue of $1.15 billion.
    Movado Group, Inc. (NYSE: MOV) is expected to report its quarterly earnings at $0.11 per share on revenue of $109.47 million.
    Chico's FAS, Inc. (NYSE: CHS) is estimated to report its quarterly earnings at $0.26 per share on revenue of $552.31 million.
    DSW Inc. (NYSE: DSW) is projected to report its quarterly earnings at $0.37 per share on revenue of $681.89 million.
    Daktronics, Inc. (NASDAQ: DAKT) is expected to report its quarterly earnings at $0.05 per share on revenue of $147.20 million.
    Destination XL Group, Inc. (NASDAQ: DXLG) is estimated to report a quarterly loss at $0.14 per share on revenue of $107.63 million.
    Bank of Montreal (NYSE: BMO) is expected to report its quarterly earnings at $1.67 per share on revenue of $4.21 billion.
    MakeMyTrip Limited (NASDAQ: MMYT) is projected to report its quarterly loss at $0.39 per share on revenue of $143.03 million.
    EVINE Live Inc. (NASDAQ: EVLV) is expected to report its quarterly loss at $0.02 per share on revenue of $155.98 million.
    RBC Bearings Incorporated (NASDAQ: ROLL) is estimated to report its quarterly earnings at $1.14 per share on revenue of $175.55 million.

     

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 11.6 percent to $3.13 in pre-market trading after surging 118.52 percent on Tuesday.
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares fell 6.5 percent to $2.60 in pre-market trading after rising 1.09 percent on Tuesday.
    T2 Biosystems, Inc. (NASDAQ: TTOO) fell 6 percent to $7.58 in pre-market trading after dropping 9.13 percent on Tuesday.
    Era Group Inc. (NYSE: ERA) fell 4.8 percent to $12.30 in the pre-market trading session.
    DSW Inc. (NYSE: DSW) shares fell 4.1 percent to $25.00 in pre-market trading after reporting Q1 results.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) shares fell 2.7 percent to $20.25 in pre-market trading after rising 7.88 percent on Tuesday.
    Daktronics, Inc. (NASDAQ: DAKT) fell 2.5 percent to $9.81 in pre-market trading. Daktronics is expected to release quarterly earnings today.
    AngloGold Ashanti Limited (NYSE: AU) fell 2.2 percent to $8.28 in pre-market trading

  • [By Lisa Levin]

    Shares of Daktronics, Inc. (NASDAQ: DAKT) were down 17 percent to $8.30 after reporting weaker-than-expected quarterly results.

    Michael Kors Holdings Limited (NYSE: KORS) was down, falling around 12 percent to $59.9675. Michael Kors reported better-than-expected earnings for its fiscal fourth quarter and issued strong first-quarter guidance. However, the company issued cautious profit guidance for the full year.

Top Performing Stocks For 2019: InterOil Corporation(IOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    I/O Coin (CURRENCY:IOC) traded 26.1% higher against the US dollar during the one day period ending at 22:00 PM E.T. on August 17th. Over the last seven days, I/O Coin has traded up 50% against the US dollar. One I/O Coin coin can now be purchased for $0.39 or 0.00005901 BTC on exchanges. I/O Coin has a market capitalization of $6.55 million and approximately $14,268.00 worth of I/O Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Media headlines about InterOil (NYSE:IOC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. InterOil earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news articles about the oil and gas company an impact score of 45.5148763796823 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top Performing Stocks For 2019: Ossen Innovation Co., Ltd.(OSN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
    Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
    Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
    California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
    Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
    Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
    Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
    Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
    Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
    Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
    Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
  • [By Stephan Byrd]

    News articles about Ossen Innovation (NASDAQ:OSN) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ossen Innovation earned a news impact score of 0.21 on Accern’s scale. Accern also assigned news articles about the construction company an impact score of 45.9401388856467 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top Performing Stocks For 2019: Roadrunner Transportation Systems, Inc(RRTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Roadrunner Transportation Systems, Inc. (NYSE: RRTS) shares dropped 16 percent to $1.85. Office Depot, Inc. (NASDAQ: ODP) will replace Roadrunner Transportation Systems in the S&P SmallCap 600 on Monday, June 4.

  • [By Lisa Levin]

    Roadrunner Transportation Systems, Inc. (NYSE: RRTS) shares dropped 14 percent to $1.9025. Office Depot, Inc. (NASDAQ: ODP) will replace Roadrunner Transportation Systems in the S&P SmallCap 600 on Monday, June 4.

  • [By Stephan Byrd]

    Media headlines about Roadrunner Transportation Systems (NYSE:RRTS) have been trending positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Roadrunner Transportation Systems earned a news sentiment score of 0.25 on Accern’s scale. Accern also gave media stories about the transportation company an impact score of 49.1890734987185 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.